Close Menu

NEW YORK (GenomeWeb) — RxGenomix has partnered with Coriell Life Sciences (CLS) to offer a pharmacogenomics training, implementation, and management package to healthcare providers, the companies said today.

Under the terms of the alliance, the firms will combine Franklin, Tennessee-based RxGenomix's pharmacogenomics training and implementation program with CLS' bioinformatic services for risk analysis, reporting, and population-level healthcare analytics.

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.

Sponsored by

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.